Join us on Thursday, 27 March 2025 from 7:00 pm to 8:00 pm (AEDT) as we deliver an update on the role of SGLT2i in the management of type 2 diabetes and its complications. We will be reviewing the latest clinical evidence that has informed recent changes to reimbursement rules.
This webinar will cover:
Speakers
Click here to view the event flyer.
Click here to register for the webinar.
For any further information, please contact the ADS Secretariat via email to ads@diabetessociety.com.au